Market Overview
Catheter stabilization devices are medical products used to secure peripheral and central venous catheters to the skin, replacing traditional sutures and adhesive dressings with engineered securement systems. The category includes sutureless stabilization devices, integrated securement dressings, and dedicated catheter holder systems used across hospitals, ambulatory care, and home health settings. With a 2025 valuation near $1.89 billion and a compound annual growth rate of approximately 6.35%, the market reflects steady expansion tied directly to the broader vascular access device sector.
- •Global market value estimated at $1.89 billion in 2025, growing at roughly 6.35% CAGR.
- •Includes sutureless securement devices, integrated dressings, and mechanical stabilization systems.
- •Used primarily with peripheral IV, PICC, central venous, and extended-dwell catheters.
Growth Drivers
The principal growth drivers are rising catheter procedure volumes worldwide and stronger clinical emphasis on preventing catheter-related complications such as dislodgement, migration, and bloodstream infections. Healthcare guidelines increasingly recommend sutureless stabilization over sutures, accelerating adoption across acute and outpatient settings. Expansion of home infusion therapy, oncology treatment, and chronic disease management further enlarges the addressable patient base using vascular access devices.
- •Infection-prevention guidelines encourage sutureless securement over legacy sutures.
- •Growth in PICC, central line, and home infusion procedures lifts underlying demand.
- •Aging populations and rising chronic disease prevalence increase catheter utilization rates.
Segmentation and Regional Analysis
The market is segmented by product type (sutureless devices, integrated securement dressings, and dedicated stabilization systems), by catheter type (peripheral IV, PICC, central venous, and others), and by end user (hospitals, ambulatory surgical centers, and home care). North America represents the largest regional market due to high procedure volumes, established reimbursement pathways, and rapid uptake of guideline-aligned devices. Asia-Pacific is the fastest-growing region, supported by expanding healthcare infrastructure, growing medical device imports, and rising adoption of advanced vascular access technologies.
- •North America leads in revenue share; Asia-Pacific is the fastest-growing regional segment.
- •Hospitals account for the largest end-user share, with home care expanding rapidly.
- •PICC and central venous catheters represent the largest catheter-type subsegments.
Trends and Outlook
What are the recent trends and outlook?
Key trends shaping the market include the development of universal securement systems compatible with multiple catheter types, integration of antimicrobial and transparent dressing technologies, and design improvements for neonatal and pediatric applications. Adoption is expanding beyond hospitals into outpatient infusion centers and home-based care, supported by training programs and remote monitoring. Looking ahead, the market is expected to maintain mid-single-digit growth through 2030 as infection-prevention standards tighten and procedure volumes continue to rise globally.
- •Universal, antimicrobial, and pediatric-specific securement designs are gaining traction.
- •Shift toward outpatient and home infusion settings broadens the end-user base.
- •Market outlook remains positive, with steady growth projected through the end of the decade.
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.